Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Comparison of late gastrointestinal and genitourinary toxicity of prostate cancer patients undergoing intensity-modulated versus conventional radiotherapy using localized fields

Prostate Cancer and Prostatic Diseases volume 10, pages 82–86 (2007)Cite this article

Abstract

To compare late genitourinary (GU) and gastrointestinal (GI) toxicity of radiotherapy (RT) to localized fields for prostate cancer delivered using intensity-modulated RT (IMRT) versus conventional RT (ConvRT). The records of 461 patients were reviewed; 355 patients received IMRT and 106 received ConvRT. Late GU and GI toxicity were compared. Late GU toxicity rates were not significantly different (P=0.166); however, late GI toxicity rates were lower with IMRT (P=0.001). Regression analyses demonstrated that only IMRT use (P=0.006) predicted reduction in late GI toxicity but no factors correlated with late GU toxicity. IMRT did not influence late GU toxicity but was associated with a reduction of late GI toxicity over ConvRT.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Hanks GE . Conformal radiotherapy for prostate cancer. Ann Med 2000; 32: 57–63.

    Article  CAS  Google Scholar 

  2. Jani AB, Hellman S . Early prostate cancer: clinical decision-making. Lancet 2003; 361: 1045–1053.

    Article  Google Scholar 

  3. Pollack A, Zagars GK, Rosen II . Prostate cancer treatment with radiotherapy: maturing methods that minimize morbidity. Semin Oncol 1999; 26: 150–161.

    CAS  PubMed  Google Scholar 

  4. Goitein M . The inverse problem. Int J Radiat Oncol Biol Phys 1990; 18: 489–491.

    Article  CAS  Google Scholar 

  5. Jani AB, Roeske JC, Rash C . Intensity modulated radiotherapy (IMRT) for prostate cancer. Clin Prostate Cancer 2003; 2: 98–105.

    Article  Google Scholar 

  6. Zelefsky MJ, Fuks Z, Leibel SA . Intensity-modulated radiation therapy for prostate cancer. Semin Radiat Oncol 2002; 12: 229–237.

    Article  Google Scholar 

  7. Tubiana M, Eschwege F . Conformal radiotherapy and intensity-modulated radiotherapy – clinical data. Acta Oncol 2000; 39: 555–567.

    Article  CAS  Google Scholar 

  8. Shu HK, Lee TT, Vigneauly E, Xia P, Pickett B, Phillips TL et al. Toxicity following high-dose three-dimensional conformal and intensity-modulated radiation therapy for clinically localized prostate cancer. Urology 2001; 57: 102–107.

    Article  CAS  Google Scholar 

  9. Zelefsky MJ, Fuks Z, Hunt M, Yamada Y, Marion C, Ling CC et al. High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients. Int J Radiat Oncol Biol Phys 2002; 53: 1111–1116.

    Article  Google Scholar 

  10. Zelefsky MJ, Fuks Z, Happersett L, Lee HJ, Ling CC, Burman CM et al. Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer. Radiother Oncol 2000; 55: 241–249.

    Article  CAS  Google Scholar 

  11. Zelefsky MJ, Fuks Z, Hunt M, Lee HJ, Lombardi D, Ling CC et al. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. J Urol 2001; 166: 876–881.

    Article  CAS  Google Scholar 

  12. Teh BS, Mai WY, Uhl BM, Augspurger ME, Grant 3rd WH, Lu HH et al. Intensity-modulated radiation therapy (IMRT) for prostate cancer with the use of a rectal balloon for prostate immobilization: acute toxicity and dose-volume analysis. Int J Radiat Oncol Biol Phys 2001; 49: 705–712.

    Article  CAS  Google Scholar 

  13. De Meerleer G, Vakaet L, Meersschout S, Villeirs G, Verbaeys A, Oosterlinck W et al. Intensity-modulated radiotherapy as primary treatment for prostate cancer: acute toxicity in 114 patients. Int J Radiat Oncol Biol Phys 2004; 60: 777–787.

    Article  Google Scholar 

  14. Pollack A, Hanlon AL, Horwitz EM, Feigenberg SJ, Konski AA, Movsas B et al. Dosimetry and preliminary acute toxicity in the first 100 men treated for prostate cancer on a randomized hypofractionation dose escalation trial. Int J Radiat Oncol Biol Phys 2006; 64: 518–526.

    Article  Google Scholar 

  15. Kupelian PA, Thakkar VV, Khuntia D, Reddy CA, Klein EA, Mahadevan A . Hypofractionated intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: long-term outcomes. Int J Radiat Oncol Biol Phys 2005; 63: 1463–1468.

    Article  Google Scholar 

  16. Jani AB . The effectiveness of combining hormone therapy and radiotherapy in the treatment of prostate cancer. Expert Opin Pharmacother 2004; 5: 2469–2477.

    Article  CAS  Google Scholar 

  17. Ryu JK, Winter K, Michalski JM, Purdy JA, Markoe AM, Earle JD et al. Interim report of toxicity from 3D conformal radiation therapy (3D-CRT) for prostate cancer on 3DOG/RTOG 9406, level III (79.2 Gy). Int J Radiat Oncol Biol Phys 2002; 54: 1036–1046.

    Article  Google Scholar 

  18. Michalski JM, Winter K, Purdy JA, Wilder RB, Perez CA, Roach M et al. Preliminary evaluation of low-grade toxicity with conformal radiation therapy for prostate cancer on RTOG 9406 dose levels I and II. Int J Radiat Oncol Biol Phys 2003; 56: 192–198.

    Article  Google Scholar 

  19. Sailer SL, Chaney EL, Rosenman JG, Sherouse GW, Tepper JE . Treatment planning at the University of North Carolina at Chapel Hill. Semin Radiat Oncol 1992; 2: 267–273.

    Article  CAS  Google Scholar 

  20. Radiation Therapy Oncology Group (RTOG). Toxicity Information. Sections 7–8: Acute and Late Radiation Morbidity Criteria) http://www.rtog.org/members/toxicity/main.html.

  21. Dawson-Saunders B, Trapp RG . Basic and Clinical Biostatistics. Prentice Hall: East Norwalk, CT, 1990.

    Google Scholar 

  22. Agresti A . Categorical Data Analysis, 2nd edn. Wiley: New York, NY, 2002.

    Book  Google Scholar 

  23. Zavoina W, McKelvey RD . A statistical model for the analysis of ordinal level dependent variables. J Math Sociol 1975; 4: 103–120.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation and Cellular Oncology, University of Chicago, Chicago, IL, USA

    A B Jani, A Su, D Correa & J Gratzle

Authors
  1. A B Jani
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A Su
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. D Correa
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J Gratzle
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A B Jani.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jani, A., Su, A., Correa, D. et al. Comparison of late gastrointestinal and genitourinary toxicity of prostate cancer patients undergoing intensity-modulated versus conventional radiotherapy using localized fields. Prostate Cancer Prostatic Dis 10, 82–86 (2007). https://doi.org/10.1038/sj.pcan.4500910

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.pcan.4500910

Keywords

This article is cited by

Search

Advanced search

Quick links